AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 23- Open
- $1,232.00
- 52-wk high
- $1,292.65
- High
- $1,271.22
- 52-wk low
- $689.88
- Low
- $1,230.00
- Prev close
- $1,244.40
Smart money
Earnings
Earnings came in 39.4% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $17.60B | $19.29B | $19.80B | $22.97B |
| Cost of what it sold | $3.01B | $2.88B | $3.58B | $3.27B |
| Gross profit | $14.59B | $16.41B | $16.22B | $19.71B |
| What it spent | ||||
| Research and development | $3.47B | $3.80B | $3.51B | $3.82B |
| Sales and admin | $2.74B | $3.34B | $2.93B | $3.43B |
| Other operating costs | — | $487.5M | $928.0M | $3.48B |
| Total operating expenses | $6.21B | $7.63B | $7.37B | $10.73B |
| What was left | ||||
| Operating profit | $8.39B | $8.78B | $8.85B | $8.98B |
| Interest on debt | $179.6M | $123.0M | $332.0M | $345.0M |
| Profit before tax | $7.23B | $8.27B | $8.85B | $9.25B |
| Tax | $1.65B | $1.63B | $1.45B | $2.15B |
| Net profit | $5.58B | $6.64B | $7.40B | $7.09B |
| EBITDA | $7.88B | $8.39B | $9.69B | $9.25B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
70balanced
20D volatility
40%annualized
52-week range
$689.88$1292.65
20D support
News
What the news says
50 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement
Leans bearishAug 20HELP Stock Jumps 6% After TD Cowen Hikes Target Nearly 8x To $62
BullishAug 20Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug
BullishAug 20
